Healthcare Sales & Marketing Network News: BCR-ABL inhibitors

Searching News Database: BCR-ABL inhibitors

HSMN NewsFeed - 2 Jul 2013
ARIAD Announces Marketing Authorization for Iclusig(R) (ponatinib) in the European Union
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 20 Nov 2007
SGX Pharmaceuticals Announces $25 Million Private Placement
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Dec 2006
INNOVIVE Pharmaceuticals Presents Data on Oncology Drug Programs in Chronic Myelogenous Leukemia and Acute Myelogenous Leukemia at American Society of Hematology 48th Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Aug 2006
SGX Pharmaceuticals Appoints Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2006
SGX Pharmaceuticals Announces Strategic Collaboration to Develop and Commercialize BCR-ABL Inhibitors for the Treatment of Chronic Myelogenous Leukemia (CML)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 5 Jan 2006
Innovive Pharmaceuticals Licenses Potent Dual Bcr-Abl/Lyn Kinase Inhibitor
Biopharmaceuticals Oncology Licensing

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.